应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00867 康哲药业
已收盘 05-09 16:08:07
8.340
-0.190
-2.23%
最高
8.680
最低
8.330
成交量
492.30万
今开
8.480
昨收
8.530
日振幅
4.10%
总市值
203.46亿
流通市值
203.46亿
总股本
24.40亿
成交额
4,151万
换手率
0.20%
流通股本
24.40亿
市净率
1.16
ROE
10.09%
每股收益
0.72
52周最高
10.127
52周最低
5.997
市盈率
11.63
股息
0.29
股息收益率
0.03
ROA
5.77%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
手握重磅单品,康哲药业子公司冲刺港股IPO
健识局 · 12:59
手握重磅单品,康哲药业子公司冲刺港股IPO
康哲药业05月09日主力净流出57.8万元 散户资金买入
市场透视 · 08:15
康哲药业05月09日主力净流出57.8万元 散户资金买入
康哲药业05月08日获主力加仓146.6万元
市场透视 · 05-08 08:15
康哲药业05月08日获主力加仓146.6万元
康哲药业04月30日获主力加仓177.5万元
市场透视 · 04-30
康哲药业04月30日获主力加仓177.5万元
康哲药业拟分拆德镁医药上市 瞄准皮肤健康市场
证券日报 · 04-29
康哲药业拟分拆德镁医药上市 瞄准皮肤健康市场
康哲药业分拆德镁医药上市,后者连续三年亏损
新京报 · 04-27
康哲药业分拆德镁医药上市,后者连续三年亏损
市值两百亿药企分拆!“皮肤”业务将上市……
国际金融报 · 04-25
市值两百亿药企分拆!“皮肤”业务将上市……
德镁医药拟登陆联交所主板 专注皮肤健康领域创新
DoNews · 04-24
德镁医药拟登陆联交所主板 专注皮肤健康领域创新
康哲药业(00867)拟分拆德镁医药上市,业务聚焦推动估值提升
智通财经 · 04-24
康哲药业(00867)拟分拆德镁医药上市,业务聚焦推动估值提升
每日卖空追踪 | 康哲药业 04月23日卖空量成交279.8万股,卖空比例为11.89%
市场透视 · 04-23
每日卖空追踪 | 康哲药业 04月23日卖空量成交279.8万股,卖空比例为11.89%
康哲药业分拆“德镁医药”,来自海南海口,拟以介绍方式赴香港上市,递交上市申请
市场资讯 · 04-23
康哲药业分拆“德镁医药”,来自海南海口,拟以介绍方式赴香港上市,递交上市申请
康哲药业盘中涨超4% 建议分拆德镁医药股份于联交所主板独立上市
新浪网 · 04-23
康哲药业盘中涨超4% 建议分拆德镁医药股份于联交所主板独立上市
中金:维持康哲药业“跑赢行业”评级 目标价11.00港元
新浪港股 · 04-23
中金:维持康哲药业“跑赢行业”评级 目标价11.00港元
港股异动 | 康哲药业(00867)涨超4% 建议分拆德镁医药股份于联交所主板独立上市
智通财经 · 04-23
港股异动 | 康哲药业(00867)涨超4% 建议分拆德镁医药股份于联交所主板独立上市
康哲药业盘中异动 早盘股价大涨5.04%报8.550港元
市场透视 · 04-23
康哲药业盘中异动 早盘股价大涨5.04%报8.550港元
中金:维持康哲药业(00867)“跑赢行业”评级 目标价11.00港元
智通财经 · 04-23
中金:维持康哲药业(00867)“跑赢行业”评级 目标价11.00港元
康哲药业:分拆德镁医药上市 潜力有望迎来释放
中金公司 · 04-22
康哲药业:分拆德镁医药上市 潜力有望迎来释放
康哲药业(00867)建议分拆德镁医药股份于联交所主板独立上市
智通财经 · 04-22
康哲药业(00867)建议分拆德镁医药股份于联交所主板独立上市
康哲药业04月22日获主力加仓829万元
市场透视 · 04-22
康哲药业04月22日获主力加仓829万元
康哲药业盘中异动 早盘股价大涨5.31%
市场透视 · 04-22
康哲药业盘中异动 早盘股价大涨5.31%
加载更多
公司概况
公司名称:
康哲药业
所属市场:
SEHK
上市日期:
--
主营业务:
康哲药业控股有限公司是一家主要从事医药产品的制造、推广、营销及销售业务的香港投资控股公司。其直接网络主要产品包括黛力新、优思弗、新活素、莎尔福、亿活及施图伦滴眼液等。其代理商推广网络产品包括沙多力卡、伊诺舒及喜达康等。其产品用于治疗胃病、心脏病、外伤感染、肝病及眼疾等。
发行价格:
--
{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"康哲药业","latestPrice":8.34,"timestamp":1746778087011,"preClose":8.53,"halted":0,"volume":4923000,"delay":0,"floatShares":2439528512,"shares":2439528512,"eps":0.7172020995426545,"marketStatus":"已收盘","change":-0.19,"latestTime":"05-09 16:08:07","open":8.48,"high":8.68,"low":8.33,"amount":41514535,"amplitude":0.041032,"askPrice":8.38,"askSize":6000,"bidPrice":8.34,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.7172020995426545,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"exchange":"SEHK","adjPreClose":8.53,"dividendRate":0.03423,"openAndCloseTimeList":[[1746754200000,1746763200000],[1746766800000,1746777600000]],"volumeRatio":0.737487,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867","defaultTab":"news","newsList":[{"id":"2534825104","title":"手握重磅单品,康哲药业子公司冲刺港股IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2534825104","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534825104?lang=zh_cn&edition=full","pubTime":"2025-05-09 20:59","pubTimestamp":1746795540,"startTime":"0","endTime":"0","summary":"来源:健识局4月22日,德镁医药向港交所递交招股书,拟于主板上市。德镁医药由上市公司康哲药业拆分而来,专注皮肤健康业务,手里已经有三款创新药产品上市,2024年收入超过6亿元,按照皮肤科处方药收入计算,居国内首位。2024年9月,德镁医药的芦可替尼乳膏的新药上市申请获国家药监局受理。目前,德镁医药已经覆盖全国超过1万家医院、10万家线下药店,在国内皮肤科领域居前列。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2025-05-09/doc-inevynpv8525844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSTECH","YANG","SG9999004220.SGD","BK1593","IE00BMCWC346.EUR","SG9999015952.SGD","LU2488822045.USD","BK4614","HSCEI","00867","SG9999015978.USD","SG9999015945.SGD","IE00BYV24P56.USD","SG9999015986.USD","BK1191"],"gpt_icon":1},{"id":"2534727961","title":"康哲药业05月09日主力净流出57.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2534727961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534727961?lang=zh_cn&edition=full","pubTime":"2025-05-09 16:15","pubTimestamp":1746778524,"startTime":"0","endTime":"0","summary":"05月09日, 康哲药业股价跌2.23%,报收8.34元,成交金额4151.5万元,换手率0.20%,振幅4.10%,量比0.74。康哲药业今日主力资金(超大单+大单)净流出57.8万元,上一交易日主力净流入146.6万元。|05月09日主力加仓幅度排名||#|股票简称|主力净额占比|#|中新控股|2.48%|#|GBA集团|2.24%|#|协同通信|1.56%|#|...|...|#2315|康哲药业|-0.00%|(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174915a6d8e76b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509174915a6d8e76b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015986.USD","SG9999015945.SGD","LU2488822045.USD","SG9999004220.SGD","BK1191","SG9999015952.SGD","00867","IE00BYV24P56.USD","IE00BMCWC346.EUR","SG9999015978.USD","BK1593"],"gpt_icon":0},{"id":"2533590983","title":"康哲药业05月08日获主力加仓146.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533590983","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533590983?lang=zh_cn&edition=full","pubTime":"2025-05-08 16:15","pubTimestamp":1746692150,"startTime":"0","endTime":"0","summary":"05月08日, 康哲药业股价涨2.52%,报收8.53元,成交金额6298.6万元,换手率0.31%,振幅4.21%,量比1.09。康哲药业今日主力资金净流入146.6万元,连续3日净流入,上一交易日主力净流入87.0万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为38.46%,平均涨幅为1.96%。该股近5个交易日上涨4.40%,主力资金累计净流入737.5万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入851.9万元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508174201a4767fa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508174201a4767fa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","SG9999015978.USD","00867","SG9999015952.SGD","SG9999004220.SGD","SG9999015986.USD","SG9999015945.SGD","IE00BYV24P56.USD","BK1191","LU2488822045.USD","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2531089772","title":"康哲药业04月30日获主力加仓177.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531089772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531089772?lang=zh_cn&edition=full","pubTime":"2025-04-30 16:15","pubTimestamp":1746000912,"startTime":"0","endTime":"0","summary":"04月30日, 康哲药业股价涨1.47%,报收8.30元,成交金额5070.4万元,换手率0.25%,振幅2.57%,量比0.42。康哲药业今日主力资金净流入177.5万元,上一交易日主力净流入183.8万元。该股近5个交易日下跌0.63%,主力资金累计净流入773.2万元;近20日主力资金累计净流入1888.1万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170226a6ce97fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430170226a6ce97fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BMCWC346.EUR","00867","SG9999015978.USD","SG9999015986.USD","IE00BYV24P56.USD","BK1191","SG9999015952.SGD","LU2488822045.USD","BK1593","SG9999015945.SGD","SG9999004220.SGD"],"gpt_icon":0},{"id":"2531126962","title":"康哲药业拟分拆德镁医药上市 瞄准皮肤健康市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2531126962","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531126962?lang=zh_cn&edition=full","pubTime":"2025-04-29 10:06","pubTimestamp":1745892408,"startTime":"0","endTime":"0","summary":"本报讯(记者李雯珊)近日,康哲药业控股有限公司(以下简称“康哲药业”)发布公告,拟将旗下皮肤业务子公司德镁医药分拆并于中国香港联交所主板上市。分拆计划拟通过实物分派形式推进,康哲药业将其所持全部德镁医药股份按比例无偿分派给现有股东。德镁医药同日以介绍上市方式提交了上市申请,不涉及新股发行,股东权益不被稀释。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504293392497449.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","IE00BYV24P56.USD","SG9999015986.USD","LU2488822045.USD","SG9999015978.USD","IE00BMCWC346.EUR","SG9999015952.SGD","BK1161","BK1191","09939","SG9999004220.SGD","SG9999015945.SGD","BK1593","BK1574","00867"],"gpt_icon":0},{"id":"2530453738","title":"康哲药业分拆德镁医药上市,后者连续三年亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2530453738","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530453738?lang=zh_cn&edition=full","pubTime":"2025-04-27 21:38","pubTimestamp":1745761125,"startTime":"0","endTime":"0","summary":"港股上市公司康哲药业近日发布公告,将附属公司德镁医药股份分拆并于联交所主板独立上市。德镁医药主要负责康哲药业在国内的皮肤健康业务,最近三年均处亏损状态。目前,德镁医药已向联交所递交申请,康哲药业表示,分拆预计将通过由康哲药业以实物方式向股东分派其持有的所有德镁医药股份的方式实施。德镁医药为康哲药业附属公司,德镁医药90.8%权益由康哲药业实益拥有。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504273390338112.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504273390338112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999015952.SGD","IE00BMCWC346.EUR","LU2488822045.USD","BK1574","IE00BYV24P56.USD","SG9999015945.SGD","SG9999015978.USD","00867","BK1593","SG9999015986.USD","09939","BK1191","BK1515","SG9999004220.SGD","BK1161"],"gpt_icon":0},{"id":"2530188793","title":"市值两百亿药企分拆!“皮肤”业务将上市……","url":"https://stock-news.laohu8.com/highlight/detail?id=2530188793","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530188793?lang=zh_cn&edition=full","pubTime":"2025-04-25 18:28","pubTimestamp":1745576920,"startTime":"0","endTime":"0","summary":"近日,康哲药业(00867.HK)发布公告,建议将旗下皮肤业务附属公司德镁医药股份分拆并在港交所主板独立上市。同时,德镁医药有限公司(下称“德镁医药”)向港交所提交了上市申请,独家保荐人为华泰国际。需要指出的是,康哲药业此次分拆将以实物方式向其股东分派其持有的所有德镁医药股份,而德镁医药以介绍方式在香港主板上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504253388975578.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504253388975578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PN","SG9999015986.USD","09939","BK1593","BK4096","BK1161","LU2488822045.USD","IE00BYV24P56.USD","BK1191","SG9999004220.SGD","SG9999015952.SGD","SG9999015978.USD","BK1574","SG9999015945.SGD","BK1515","IE00BMCWC346.EUR","00867"],"gpt_icon":0},{"id":"2529609393","title":"德镁医药拟登陆联交所主板 专注皮肤健康领域创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2529609393","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529609393?lang=zh_cn&edition=full","pubTime":"2025-04-24 18:18","pubTimestamp":1745489882,"startTime":"0","endTime":"0","summary":"4月22日,德镁医药有限公司向香港联交所递交上市申请,计划以介绍方式在主板挂牌,华泰国际担任独家保荐人。同日,其母公司康哲药业宣布拟分拆德镁医药独立上市,将通过实物分派方式向股东分配所持德镁医药股份。德镁医药是一家专注于皮肤健康的创新型医药企业,覆盖皮肤处方药及护肤品的研发、生产与销售。财务数据显示,2022年至2024年,德镁医药收入逐年增长,但同期净利润波动较大,毛利率介于63.5%至76.9%之间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042418214697436a42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042418214697436a42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU2488822045.USD","BK1161","SG9999015986.USD","BK1191","09939","IE00BMCWC346.EUR","SG9999004220.SGD","IE00BYV24P56.USD","SG9999015978.USD","BK1574","BK1593","SG9999015952.SGD","SG9999015945.SGD","00867"],"gpt_icon":0},{"id":"2529183876","title":"康哲药业(00867)拟分拆德镁医药上市,业务聚焦推动估值提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2529183876","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529183876?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:42","pubTimestamp":1745458940,"startTime":"0","endTime":"0","summary":"智通财经APP了解到,4月22日,康哲药业宣布,建议将旗下皮肤业务子公司德镁医药股份分拆并于香港联交所主板独立上市。康哲药业认为,该分拆完成后,余下集团和分拆集团都将受益,德镁医药预计将可独立进行筹资活动,余下集团将可集中资源发展其核心业务。皮肤健康业务展现强劲增长潜力此次拟分拆上市的德镁医药,业务围绕皮肤处方药及皮肤学级护肤品的研产销,提供从预防、治疗到长期护理的皮肤健康综合解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1283739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK1161","BK1191","SG9999015952.SGD","IE00BYV24P56.USD","00867","09939","BK1593","IE00BMCWC346.EUR","159938","SG9999004220.SGD","SG9999015978.USD","SG9999015986.USD","LU2488822045.USD","SG9999015945.SGD"],"gpt_icon":0},{"id":"2529578580","title":"每日卖空追踪 | 康哲药业 04月23日卖空量成交279.8万股,卖空比例为11.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529578580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529578580?lang=zh_cn&edition=full","pubTime":"2025-04-23 17:09","pubTimestamp":1745399368,"startTime":"0","endTime":"0","summary":"康哲药业北京时间04月23日,涨4.79%,卖空量成交279.8万股,较上一交易日增加148.05%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423172043a463afce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423172043a463afce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015945.SGD","BK1191","SG9999004220.SGD","SG9999015978.USD","BK1593","IE00BMCWC346.EUR","SG9999015986.USD","SG9999015952.SGD","LU2488822045.USD","00867","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2529545328","title":"康哲药业分拆“德镁医药”,来自海南海口,拟以介绍方式赴香港上市,递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2529545328","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529545328?lang=zh_cn&edition=full","pubTime":"2025-04-23 13:04","pubTimestamp":1745384640,"startTime":"0","endTime":"0","summary":" 2025年4月22日,康哲药业分拆德镁医药有限公司Dermavon Holdings Limited在港交所递交上市申请,拟以介绍方式在香港主板上市。 德镁医药,成立于2020年,总部位于海南海口,作为一家中国领先、专业聚焦皮肤健康的创新型医药企业,围绕皮肤处方药及皮肤学级护肤品的研、产、销一体化运营,致力于提供从预防、治疗到长期护理的皮肤健康综合解决方案。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-04-23/doc-ineucptw3299749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999015978.USD","IE00BYV24P56.USD","09939","SG9999015952.SGD","SG9999015986.USD","BK1515","SG9999015945.SGD","BK1191","BK1574","IE00BMCWC346.EUR","SG9999004220.SGD","159938","LU2488822045.USD","BK1593","00867","BK1161"],"gpt_icon":0},{"id":"2529851655","title":"康哲药业盘中涨超4% 建议分拆德镁医药股份于联交所主板独立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529851655","media":"新浪网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529851655?lang=zh_cn&edition=full","pubTime":"2025-04-23 10:32","pubTimestamp":1745375552,"startTime":"0","endTime":"0","summary":"康哲药业盘中涨超4%,截至发稿,股价上涨2.95%,现报8.38港元,成交额7606.41万港元。4月22日晚间,康哲药业发布公告,公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆(倘进行)预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施,分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042311020294def9d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042311020294def9d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","IE00BYV24P56.USD","SG9999015986.USD","LU2488822045.USD","SG9999015978.USD","IE00BMCWC346.EUR","SG9999015952.SGD","BK1161","BK1191","09939","SG9999004220.SGD","SG9999015945.SGD","BK1593","BK1574","00867"],"gpt_icon":0},{"id":"2529597518","title":"中金:维持康哲药业“跑赢行业”评级 目标价11.00港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529597518","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529597518?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:55","pubTimestamp":1745373300,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 中金发布研报称,维持康哲药业(00867)盈利预测不变,公司股价当前交易于10.8倍/9.7倍2025/2026年经调整市盈率,维持跑赢行业评级和11.00港元目标价不变,对应14.6倍/13.1倍2025/2026年经调整市盈率。4月22日晚,公司公告建议分拆子公司德镁医药于港交所主板独立上市,分拆建议仍需取决于相关部门批准、公司董事会以及德镁医药董事会批准。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:史丽君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2025-04-23/doc-ineucinc4606666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00867"],"gpt_icon":0},{"id":"2529920385","title":"港股异动 | 康哲药业(00867)涨超4% 建议分拆德镁医药股份于联交所主板独立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529920385","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529920385?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:50","pubTimestamp":1745373044,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,康哲药业涨超4%,截至发稿,涨4.67%,报8.52港元,成交额3570.65万港元。消息面上,4月22日晚间,康哲药业发布公告,公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆(倘进行)预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施,分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","IE00BYV24P56.USD","SG9999015952.SGD","BK1574","BK1191","BK1161","SG9999015945.SGD","159938","09939","BK1515","SG9999004220.SGD","SG9999015978.USD","BK1593","SG9999015986.USD","IE00BMCWC346.EUR","00867"],"gpt_icon":0},{"id":"2529592679","title":"康哲药业盘中异动 早盘股价大涨5.04%报8.550港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529592679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529592679?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:37","pubTimestamp":1745372279,"startTime":"0","endTime":"0","summary":"2025年04月23日早盘09时37分,康哲药业股票出现波动,股价急速上涨5.04%。截至发稿,该股报8.550港元/股,成交量219.3万股,换手率0.09%,振幅4.05%。资金方面,该股资金流入1027.73万港元,流出598.138万港元。最近的财报数据显示,该股实现营业收入80.66亿港元,净利润17.49亿港元,每股收益0.72港元,毛利58.55亿港元,市盈率11.92倍。康哲药业股票所在的药品行业中,整体涨幅为0.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093759974163a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423093759974163a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","SG9999015986.USD","IE00BYV24P56.USD","LU2488822045.USD","BK1593","SG9999015978.USD","SG9999004220.SGD","SG9999015945.SGD","SG9999015952.SGD","00867","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2529392592","title":"中金:维持康哲药业(00867)“跑赢行业”评级 目标价11.00港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529392592","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529392592?lang=zh_cn&edition=full","pubTime":"2025-04-23 09:30","pubTimestamp":1745371834,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中金发布研报称,维持康哲药业盈利预测不变,公司股价当前交易于10.8倍/9.7倍2025/2026年经调整市盈率,维持跑赢行业评级和11.00港元目标价不变,对应14.6倍/13.1倍2025/2026年经调整市盈率。目前德镁医药90.8%股权由康哲药业持有,9.2%股权由两个员工激励平台持有。分拆完成上市后,康哲药业与德镁医药将各自拥有独立上市地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00867"],"gpt_icon":0},{"id":"2529996305","title":"康哲药业:分拆德镁医药上市 潜力有望迎来释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2529996305","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529996305?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:00","pubTimestamp":1745337600,"startTime":"0","endTime":"0","summary":"公司近况4 月22 日晚,公司公告建议分拆子公司德镁医药于港交所主板独立上市,分拆建议仍需取决于相关部门批准、公司董事会以及德镁医药董事会批准。根据公告,建议分拆(若进行)采用实物方式向股东分派其持有所有德镁医药股份方式实施,股东享有的德镁医药股权不会被稀释。目前德镁医药90.8%股权由康哲药业持有,9.2%股权由两个员工激励平台持有。分拆完成上市后,康哲药业与德镁医药将各自拥有独立上市地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423090620a6c475ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423090620a6c475ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","SG9999015945.SGD","BK1574","09939","IE00BYV24P56.USD","SG9999015986.USD","LU2488822045.USD","BK1593","SG9999015978.USD","SG9999004220.SGD","BK1515","SG9999015952.SGD","00867","BK1161","IE00BMCWC346.EUR"],"gpt_icon":0},{"id":"2529585619","title":"康哲药业(00867)建议分拆德镁医药股份于联交所主板独立上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2529585619","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529585619?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:36","pubTimestamp":1745329000,"startTime":"0","endTime":"0","summary":"智通财经APP讯,康哲药业 公布,公司建议将公司附属公司德镁医药股份分拆并于联交所主板独立上市。建议分拆(倘进行)预计将透过由公司以实物方式向股东分派其持有的所有德镁医药股份的方式实施,分派比例将按截至董事会为确定股东权利而厘定的记录日期当日彼等各自于公司的持股比例计算。联交所已确认公司可进行建议分拆事宜。据悉,德镁医药是一家在开曼群岛注册成立的获豁免有限公司,为公司的附属公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1282603.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","LU2488822045.USD","SG9999015978.USD","SG9999015986.USD","SG9999015952.SGD","BK1191","BK1515","00867","BK1574","SG9999004220.SGD","09939","IE00BMCWC346.EUR","BK1161","IE00BYV24P56.USD","159938","SG9999015945.SGD"],"gpt_icon":0},{"id":"2529831321","title":"康哲药业04月22日获主力加仓829万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529831321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529831321?lang=zh_cn&edition=full","pubTime":"2025-04-22 16:16","pubTimestamp":1745309765,"startTime":"0","endTime":"0","summary":"04月22日, 康哲药业股价涨10.75%,报收8.14元,成交金额1.14亿元,换手率0.58%,振幅12.24%,量比1.74。康哲药业今日主力资金净流入829万元,上一交易日主力净流入153万元。该股近5个交易日上涨9.82%,主力资金累计净流入1460万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入5460万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171027a4623a7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422171027a4623a7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999015986.USD","SG9999004220.SGD","BK1191","BK1593","LU2488822045.USD","SG9999015952.SGD","SG9999015978.USD","IE00BMCWC346.EUR","SG9999015945.SGD","00867","IE00BYV24P56.USD"],"gpt_icon":0},{"id":"2529836034","title":"康哲药业盘中异动 早盘股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529836034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529836034?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:34","pubTimestamp":1745285689,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时34分,康哲药业股票出现异动,股价急速上涨5.31%。截至发稿,该股报7.740港元/股,成交量65.8619万股,换手率0.03%,振幅5.31%。机构评级方面,在所有10家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。康哲药业股票所在的药品行业中,整体涨幅为0.24%。其相关个股中,三生制药、远大医药、石药集团涨幅较大,振幅较大的相关个股有石药集团、和黄医药、远大医药,振幅分别为7.19%、6.33%、6.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093449973ff82c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093449973ff82c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BYV24P56.USD","BK1593","IE00BMCWC346.EUR","SG9999015945.SGD","SG9999015952.SGD","BK1191","SG9999015978.USD","SG9999004220.SGD","LU2488822045.USD","SG9999015986.USD","00867"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":0.0277},{"period":"1month","weight":0.1977},{"period":"3month","weight":0.1408},{"period":"6month","weight":0.0947},{"period":"1year","weight":0.2242},{"period":"ytd","weight":0.1468}],"compareEarnings":[{"period":"1week","weight":0.0297},{"period":"1month","weight":0.1316},{"period":"3month","weight":0.0777},{"period":"6month","weight":0.0988},{"period":"1year","weight":0.2436},{"period":"ytd","weight":0.1354}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康哲药业控股有限公司是一家主要从事医药产品的制造、推广、营销及销售业务的香港投资控股公司。其直接网络主要产品包括黛力新、优思弗、新活素、莎尔福、亿活及施图伦滴眼液等。其代理商推广网络产品包括沙多力卡、伊诺舒及喜达康等。其产品用于治疗胃病、心脏病、外伤感染、肝病及眼疾等。","yearOnYearQuotes":[{"month":1,"riseRate":0.466667,"avgChangeRate":0.00581},{"month":2,"riseRate":0.571429,"avgChangeRate":0.034294},{"month":3,"riseRate":0.466667,"avgChangeRate":-0.002345},{"month":4,"riseRate":0.533333,"avgChangeRate":0.029496},{"month":5,"riseRate":0.466667,"avgChangeRate":-0.006143},{"month":6,"riseRate":0.642857,"avgChangeRate":-0.002212},{"month":7,"riseRate":0.5,"avgChangeRate":-0.017266},{"month":8,"riseRate":0.428571,"avgChangeRate":0.023893},{"month":9,"riseRate":0.428571,"avgChangeRate":0.001077},{"month":10,"riseRate":0.533333,"avgChangeRate":0.011618},{"month":11,"riseRate":0.6,"avgChangeRate":0.058512},{"month":12,"riseRate":0.6,"avgChangeRate":0.038699}],"exchange":"SEHK","name":"康哲药业","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康哲药业,00867,康哲药业股票,康哲药业股票老虎,康哲药业股票老虎国际,康哲药业行情,康哲药业股票行情,康哲药业股价,康哲药业股市,康哲药业股票价格,康哲药业股票交易,康哲药业股票购买,康哲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}